Natural Products
| Catalog No. | Information |
| CFN95362 | ZP-amide C |
| CFN95361 | Foliachinenoside C |
| CFN95360 | Apigenin 6,8-di-C-alpha-L-arabinopyranoside |
| CFN95359 | Dipsacus saponin X |
| CFN95358 | Acacetin 7-[rhamnosyl-(1->2)-galacturonide] |
| CFN95357 | Kaempferol 3,4'-di-O-glucoside Kaempferol 3,4'-diglucoside causing the blueing effects on anthocyanin |
| CFN95356 | 8-Hydroxypinoresinol-4'-O-beta-D-glucopyranoside |
| CFN95355 | Hederagenin 3-O-(2-O-acetyl-alpha-L-arabinopyranoside) Hederagenin 3-O-(2-O-acetyl-α-L-arabinopyranoside) significantly increased alkaline phosphatase (ALP) activity and the level of protein expression of bone sialoprotein (BSP) and osteocalcin (OC) . |
| CFN95354 | Japondipsaponin E1 |
| CFN95353 | Dipsacussaponin C Dipsacussaponin C potently induces procoagulant activity in platelets and leads to increased thrombus formation. DSC has an antinociceptive effect when it is administered supraspinally and GABAA, NMDA and non-NMDA receptors, but not opioid and GABAB receptors located at the supraspinal level, may be involved in DSC-induced antinociception. Dipsacus saponin C evoked hemolysis directly on the erythrocytes. |
| CFN95352 | Apigenin 7-[rhamnosyl-(1->2)-galacturonide] |
| CFN95351 | New compound 11 |
| CFN95350 | Isospinosin |
| CFN95349 | trans-Psoralenoside Trans-Psoralenoside has hepatoprotective, kidney protection, antiulcer and anticoagulant activities. |
| CFN95348 | Planispine A Planispine A has Anti-inflammatory activity. |
| CFN95347 | Secotubeimoside I Reference standards; tubeimoside I analogue. |
| CFN95346 | Dioscoreside E Dioscoreside E showed cytotoxic activity and Anti-fungal activity against a panel of tumor cell lines. |
| CFN95345 | Dioscoreside C Dioscoreside C showed mild cytotoxicity against the cancer cell lines, A375, L929, and HeLa, in a dose-dependent manner. |
| CFN95344 | 4'-O-Methyllucenin II (Diosmetin 6,8-di-C-glucoside) Diosmetin 6,8-di-C-glucoside has antioxidant and anti-aging activities. |
| CFN95343 | New compound 10 |
| CFN95342 | New compound 9 |
| CFN95341 | New compound 8 |
| CFN95340 | Deoxy euphorbia factor L1 Deoxy euphorbia factor L1 inhibits the growth of lung cancer A549 cells through the mitochondrial pathway (IC50 value of 17.51 ± 0.85 μM) and induces apoptosis. |
| CFN95339 | Euphorbia factor L25 Reference standards. Euphorbia factor L1 analogue. |
| CFN95338 | Euphorbia factor L22 Reference standards. Euphorbia factor L1 analogue. |
| CFN95337 | Fuzitine |
| CFN95336 | Peiioside B |
| CFN95335 | 9,11-Dehydro-beta-boswellic acid 9,11-Dehydro-β-boswellic acid has urease inhibitory activity. 9,11-Dehydro-beta-boswellic acid inhibiting the key enzyme of leukotriene biosynthesis, 5-lipoxygenase (5-LO). |
| CFN95334 | Euphorbia factor L24 Reference standards. Euphorbia factor L1 analogue. |
| CFN95333 | Diosniposide B |
| CFN95332 | Notoginsenoside L13 Reference standards |
| CFN95331 | Gynosaponin TN2 Gynosaponin TN-2 has anti-Parkinsonian activity. Gynosaponin TN-2 exerts protective effects on L-DOPA (100 and 200 μM)-induced apoptotic cell death by modulating extracellular signal-regulated protein kinases 1 and 2 activation in pheochromocytoma 12 cells. |
| CFN91712 | Tubuloside B Tubuloside B has the neuroprotective capacity to antagonize TNFalpha-induced apoptosis in SH-SY5Y cells and may be useful in treating some neurodegenerative diseases. Tubuloside B possesses antioxidative effects. Tubuloside B may be applied as an antiparkinsonian agent. |
| CFN95330 | New compound 7 |
| CFN95329 | Physalin X Physalin X exhibited inhibitory activities on NO production with IC50 values of 68.50μM. |
| CFN95328 | Isophysalin G Reference standards. Physalin G analogue. |
| CFN95327 | Arvenin III |
| CFN95326 | Isocucurbitacin D Isocucurbitacin D showed a cytotoxic effect with disruption of target protein cofilin. Isocucurbitacin D exhibited the highest activities of improved the LDL uptake rate.Isocucurbitacin D dose-dependently increased LDLR protein levels and decreased PCSK9 protein levels. |
| CFN95325 | Lathyranoic acid A |
| CFN95324 | Parishin G |
| CFN95323 | Cuscutamine Cuscutamine has luciferase-inducing activity and can significantly stimulate cancer cell proliferation |
| CFN95322 | alpha-Costic acid α-Costic acid, a plant sesquiterpene with acaricidal activity against Varroa destructor. Alpha-Costic acid is a potential biocide against two fungal strains, Penicillium roqueforti and Aspergillus niger. α-costic acid had a suppressive effect on the dodder seed germination but had a stimulating action on the broomrape seed germination. |
| CFN95321 | (3beta,22alpha)-26-(beta-glucopyranosyloxy)-22-methoxyfurost-5-en-3-yl 2-O-(6-deoxy-alpha-mannopyranosyl)-beta-glucopyranosiduronic acid Anemarsaponin E analogue. Reference standards. |
| CFN95320 | Batatasin V Batatasin III analogue. Reference standards. |
| CFN95319 | Batatasin IV Batatasin III analogue. Reference standards. |
| CFN91782 | (3beta,7beta,12beta,20Z)- 3,7,12- trihydroxy-11,15,23-trioxo-lanost-8,20-dien-26-oic acid Reference standards. |
| CFN91763 | (5alpha)-11-dioxo-7,15-dihydroxy-4,4,14-trimethyl-3-Chol-8-en-24-oic acid |
| CFN95318 | Menisperine Anti-inflammatory effects (potential NF-κB inhibitors). |
| CFN95317 | 4,7-Didehydroneophysalin B |
| CFN95316 | 3',5-Dihydroxy-4',6,7-trimethoxyflavanone Eupatorin analog. Reference standards. |
